Companies: 10,795·Total market cap: $144.5T
Candel Therapeutics, Inc.

Candel Therapeutics, Inc.

CADLNASDAQHealthcare● Active
$8.50
$-0.01(-0.12%)
Market Cap$466657506
P/E Ratio
52W High$9.27
52W Low$4.35
Overview

Candel Therapeutics, Inc. (CADL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CADL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.98cadl eps ttm · cadl earnings per shareEarnings history
PE Ratio (TTM)cadl pe ratio ttm · cadl price to earningsPE Ratio deep dive
Revenue (TTM)0.00cadl revenue ttm · cadl annual revenueFull revenue history
Dividend YieldNo Dividenddoes cadl pay dividends · cadl dividend yieldDividend history
Shares Outstanding53.0Mcadl shares outstanding · cadl floatShares outstanding history
Next EarningsAug 13, 2026Est.cadl earnings date · cadl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
candel therapeutics, inc. revenue · cadl revenue 2025
FY 2025Net Income-$38.2M▲ +30.80% YoY
202320242025
candel therapeutics, inc. net income · cadl profit 2025
FY 2025EPS$-0.72▲ +58.62% YoY
202320242025
cadl eps · candel therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$54.4MEPS: $-0.98View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis cadl a buy · cadl analyst rating
Strong Buy
0
Buy
9
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$15.00Low
$8.50Current
$15.00Avg Target76.47% upside
$15.00High
cadl price target · cadl 12 month forecast

Total: 10 · Buy rate: 90.0%

The CADL analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +76.47% upside from the current price of $8.50.

Stock Performance

Full History
1D-0.71%
1W+1.56%
1M+1.20%
3M+71.05%
YTD+49.56%
1Y+44.20%
5Y+20.71%

About Candel Therapeutics, Inc.

CEOPaul-Peter Tak
IPO DateJul 27, 2021
Employees38
CountryUS

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-…

what is candel therapeutics, inc. · cadl stock overview · candel therapeutics, inc. company profile · who is candel therapeutics, inc. ceo · cadl NASDAQ · candel therapeutics, inc. headquarters · candel therapeutics, inc. business segments

About Stock Overview & Key Data

Candel Therapeutics, Inc. (CADL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 27, 2021. As of the latest trading session, CADL stock price is $8.50, with a market capitalization of $466.7M. The stock has returned +44.20% over the past 12 months and +49.56% year-to-date.

According to 10 Wall Street analysts, the consensus rating for Candel Therapeutics, Inc. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2025, Candel Therapeutics, Inc. reported revenue of — and net income of -$38.2M. For detailed data — including Candel Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Candel Therapeutics, Inc. (CADL) stock price is $8.50. The stock is traded on NASDAQ under the ticker symbol CADL. The 52-week range is $4.35 – $9.27.

CADL stock priceCADL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice